The Mature Activating Natural Killer Cell Immunologic Synapse is Formed in Distinct Stages
Overview
Authors
Affiliations
Natural killer (NK) cells form a structure at their interface with a susceptible target cell called the activating NK cell immunologic synapse (NKIS). The mature activating NKIS contains a central and peripheral supramolecular activation cluster (SMAC), and includes polarized surface receptors, filamentous actin (F-actin) and perforin. Evaluation of the NKIS in human NK cells revealed CD2, CD11a, CD11b and F-actin in the peripheral SMAC (pSMAC) with perforin in the central SMAC. The accumulation of F-actin and surface receptors was rapid and depended on Wiskott-Aldrich syndrome protein-driven actin polymerization. The accumulation at and arrangement of these molecules in the pSMAC was not affected by microtubule depolymerization. The polarization of perforin, however was slower and required intact actin, Wiskott-Aldrich syndrome protein, and microtubule function. Thus the process of CD2, CD11a, CD11b, and F-actin accumulation in the pSMAC and perforin accumulation in the central SMAC of the NKIS are sequential processes with distinct cytoskeletal requirements.
Tumor cells escape immunosurveillance by hampering LFA-1.
Upadhyay S, Murugu L, Svensson L Front Immunol. 2025; 16:1519841.
PMID: 39911389 PMC: 11794523. DOI: 10.3389/fimmu.2025.1519841.
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells.
Melo Garcia L, Gangadharan A, Banerjee P, Li Y, Zeng A, Rafei H Cell Rep. 2025; 44(1):115122.
PMID: 39754720 PMC: 11838179. DOI: 10.1016/j.celrep.2024.115122.
Dahlvang J, Dick J, Sangala J, Kennedy P, Pomeroy E, Snyder K J Immunol. 2023; 210(8):1108-1122.
PMID: 36881874 PMC: 10073313. DOI: 10.4049/jimmunol.2200488.
Effects of extracellular adhesion molecules on immune cell mediated solid tumor cell killing.
Kim S, Yun S, Doh J Front Immunol. 2022; 13:1004171.
PMID: 36389663 PMC: 9647090. DOI: 10.3389/fimmu.2022.1004171.
P2X7 receptor activation impairs antitumour activity of natural killer cells.
Baroja-Mazo A, Penin-Franch A, Lucas-Ruiz F, Torre-Minguela C, Alarcon-Vila C, Hernandez-Caselles T Br J Pharmacol. 2022; 180(1):111-128.
PMID: 36098250 PMC: 10092446. DOI: 10.1111/bph.15951.